Clinical Trials
17 trialsNCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05639972 2026-02-27
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
Phase 1/2 Recruiting
NCT05686226 2026-02-27
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT06582849 2025-08-26
EARN
Washington University School of Medicine
Phase NA Completed
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT04357873 2025-02-19
PEVOsq
UNICANCER
Phase 2 Completed
NCT06666634 2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA Recruiting
NCT06544720 2024-08-09
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
The Affiliated Hospital of Qingdao University
Phase 1 Recruiting
NCT03012581 2024-02-28
AcSé
UNICANCER
Phase 2 Completed
NCT03418480 2024-02-07
HARE-40
University of Southampton
Phase 1/2 Completed
NCT04574427 2022-10-19
INFLUENCE
The Netherlands Cancer Institute
Completed
NCT02981862 2021-08-31
CaptHPV
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT04905030 2021-06-11
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
Karolinska Institutet
Phase NA Unknown
NCT03346915 2019-10-09
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
Boston Medical Center
Phase NA Completed
NCT00900302 2016-02-10
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Completed
NCT00002506 2011-05-12
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Hoag Memorial Hospital Presbyterian
Phase 2 Completed